Search Orphan Drug Designations and Approvals
-
Generic Name: | recombinant human minibody against complement component C5 fused with RGD-motif |
---|---|
Date Designated: | 02/04/2009 |
Orphan Designation: | Prevention of ischemia/reperfusion injury associated with solid organ transplantation. |
Orphan Designation Status: | Designated/Designation Withdrawn or Revoked |
Date Designation Withdrawn or Revoked: | 04/04/2019 |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
ADIENNE S.A. Via Zurigo 46 6900 Lugno Switzerland The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-